![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif)
(peh-RIH-feh-rul stem sel tranz-plan-TAY-shun)
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif)
| A method of replacing blood-forming cells destroyed by cancer treatment. Immature blood cells (stem cells) in the circulating blood that are similar to those in the bone marrow are given to the patient after treatment. This helps the bone marrow recover and continue producing healthy blood cells. Transplantation may be autologous (an individual's own blood cells saved earlier), allogeneic (blood cells donated by someone else), or syngeneic (blood cells donated by an identical twin). Also called peripheral stem cell support. |
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081004120554im_/http://www.cancer.gov/images/spacer.gif) |